229 related articles for article (PubMed ID: 35846794)
1. DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis.
Lu Y; Yu J; Dong Q; Du Y; Liang Z
Int J Gen Med; 2022; 15():6127-6143. PubMed ID: 35846794
[TBL] [Abstract][Full Text] [Related]
2. DOCK4 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma.
Xie X; Lu Y; Wang B; Yin X; Chen J
Comb Chem High Throughput Screen; 2023 Sep; ():. PubMed ID: 37702239
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma.
Guo Y; Wang ZW; Su WH; Chen J; Wang YL
Biomed Res Int; 2020; 2020():4145164. PubMed ID: 32685482
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma.
Wang D; Wang QH; Luo T; Jia W; Wang J
World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549
[TBL] [Abstract][Full Text] [Related]
5. Expression and role of nuclear receptor-interacting protein 1 (NRIP1) in stomach adenocarcinoma.
Fang D; Lu G
Ann Transl Med; 2020 Oct; 8(20):1293. PubMed ID: 33209873
[TBL] [Abstract][Full Text] [Related]
6. Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma.
Huang Z; Yang H; Lao J; Deng W
PLoS One; 2023; 18(7):e0287303. PubMed ID: 37467193
[TBL] [Abstract][Full Text] [Related]
7. FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration.
Yang Y; Gao Y; Liu XS; Huang ZM; Zhang Y; Zhang YH; Liu ZY; Chen YX; Pei ZJ
Exp Ther Med; 2024 Aug; 28(2):305. PubMed ID: 38873045
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates.
He Y; Zhang H; Zhang Y; Wang P; Zhu K; Ba Y
Int J Gen Med; 2022; 15():3375-3391. PubMed ID: 35368798
[TBL] [Abstract][Full Text] [Related]
9. PLVAP protein expression correlated with microbial composition, clinicopathological features, and prognosis of patients with stomach adenocarcinoma.
Wen Y; Wang Y; Huang Y; Liu Z; Hui C
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7139-7153. PubMed ID: 36884119
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer.
Zhang T; Lai S; Cai Y; Huang Z; Li Y; Chen S; Zhang Z; Ye Z; Lai X; Zhai E; Cai S; Chen J
Front Cell Dev Biol; 2021; 9():719613. PubMed ID: 34869310
[No Abstract] [Full Text] [Related]
11. IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma.
Guo L; Fang T; Jiang Y; Liu D
Int J Gen Med; 2021; 14():9887-9902. PubMed ID: 34938108
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma.
Xu Y; Jin H; Chen Y; Yang Z; Xu D; Zhang X; Yang J; Wang Y
BMC Med Genomics; 2024 Jun; 17(1):168. PubMed ID: 38907304
[TBL] [Abstract][Full Text] [Related]
13. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma.
Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P
Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547
[TBL] [Abstract][Full Text] [Related]
14. CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer.
Cui G; Geng L; Zhu L; Lin Z; Liu X; Miao Z; Jiang J; Feng X; Wei F
J Cancer; 2021; 12(11):3378-3390. PubMed ID: 33976747
[TBL] [Abstract][Full Text] [Related]
15. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
Guo L; Liu D
Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
PeerJ; 2023; 11():e14645. PubMed ID: 36919165
[TBL] [Abstract][Full Text] [Related]
17. ASF1B acted as a prognostic biomarker for stomach adenocarcinoma.
Zhao C; Zhou J; Xing J; Yin Q
Medicine (Baltimore); 2023 Dec; 102(48):e35408. PubMed ID: 38050219
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma.
Wu B; Fu L; Guo X; Hu H; Li Y; Shi Y; Zhang Y; Han S; Lv C; Tian Y
Front Immunol; 2023; 14():984816. PubMed ID: 36761750
[TBL] [Abstract][Full Text] [Related]
19. High Expression of the Component 3a Receptor 1 (C3AR1) Gene in Stomach Adenocarcinomas Infers a Poor Prognosis and High Immune-Infiltration Levels.
Yang H; Li L; Liu X; Zhao Y
Med Sci Monit; 2021 Feb; 27():e927977. PubMed ID: 33539329
[TBL] [Abstract][Full Text] [Related]
20. Increased ANXA5 expression in stomach adenocarcinoma infers a poor prognosis and high level of immune infiltration.
Su Z; Shu K; Li G
Cancer Biomark; 2022; 35(2):155-165. PubMed ID: 35912732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
